References
- ParraBGuillain–Barré syndrome associated with Zika virus infection in ColombiaN. Engl. J. Med.2016375 1513 152310.1056/NEJMoa1605564
- HughesRAImmunotherapy for Guillain-Barré syndrome: a systematic reviewBrain20071302245225710.1093/brain/awm004
- ReesJHSoudainSEGregsonNAHughesRACampylobacter jejuni infection and Guillain–Barré syndromeN. Engl. J. Med.19953331374137910.1056/NEJM199511233332102
- IslamBEur. J. Clin. Microbiol Infect. Dis.20183751151810.1007/s10096-018-3199-5
- Cao-LormeauVGuillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control studyLancet2016100271531153910.1016/S0140-6736(16)00562-6
- AriasAGuillain-Barré syndrome in patients with a recent history of Zika in Cucuta, Colombia: a descriptive case series of 19 patients from December 2015 to March 2016J. Crit. Care.201737192310.1016/j.jcrc.2016.08.016
- AnayaJA comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in Cúcuta, ColombiaJ. Autoimmun.20177712313810.1016/j.jaut.2016.12.007
- HughesRACornblathDRGuillain-Barre syndromeLancet20053661653166610.1016/S0140-6736(05)67665-9
- GriffinJPathology of the motor‐sensory axonal Guillain‐Barré syndromeAnn. Neurol.199639172810.1002/ana.410390105
- SejvarJJGuillain–Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety dataVaccine20112959961210.1016/j.vaccine.2010.06.003
- DowdKABroadly neutralizing activity of Zika virus-immune sera identifies a single viral serotypeCell Rep.2016161485149110.1016/j.celrep.2016.07.0495004740
- FrenzenPDEconomic cost of Guillain-Barre syndrome in the United StatesNeurology200871212710.1212/01.wnl.0000316393.54258.d1
- WolfeFMichaudKPincusTDevelopment and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaireArthritis Rheumatol.2004503296330510.1002/art.20549